glp-1 muscle Loss Explained Study finds GLP-1 receptor agonists

reducing reliance on costly imports." Key findings: With 98 GLP-1 drugs in trials, patent expiry in 2026 enabling biosimilars, and a projected $150B market by 2035, China could challenge Western dominancedespite regulatory hurdles and US tariffs

Weight loss pills and a growing number of ways to buy the drugs could make them easier to access.

This article is not political.

Treatment options for these conditions are limited to invasive neurosurgery, and novel pharmacological approaches to manage ICP in pathology are sought

Explore how GLP-1 treatments impact dopamine and the brains reward system, shaping cravings, eating behavior, and daily enjoyment.

Expert guidance on safety, managing side effects, & preventing post-surgery diarrhoea.